Please login or register first to view this content.
Ophthalmic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Update on Availability of Byooviz, a Biosimilar to Lucentis
USPSTF: Evidence Lacking for Glaucoma Screening in Adults
Nyxol Ophthalmic Solution Looks Promising for Night Vision Disturbances
Verkazia Now Available for Vernal Keratoconjunctivitis
Continued Monitoring Needed for Anti-VEGF Therapy in Macular Edema
Trials Evaluating Novel Eye Drop Candidate for Presbyopia Meet Endpoints
Erectile Dysfunction Meds Tied to Higher Risk for Vision Issues
Trial Investigating New Vuity Dosing Option for Presbyopia Meets Endpoint
Xipere Now Available for Macular Edema Associated With Uveitis
Pegcetacoplan Continues to Reduce Geographic Atrophy Lesion Growth: 18-Month Data
Lastacaft Eye Drops Now Available Over-the-Counter
FDA Approves Disposable Contacts With Antihistamine for Allergic Conjunctivitis
Trials Show Promise for Intravitreal Faricimab in Retinal Disease
First Generic Version of Restasis Gets FDA Approval
January 2022: 5 Notable Drug Approvals
Vabysmo Approved for Wet AMD, Diabetic Macular Edema
Kimmtrak Approved for Unresectable or Metastatic Uveal Melanoma
Intravitreal Gene Therapy Fast Tracked for X-Linked Retinitis Pigmentosa